STOCK TITAN

LifeStance (LFST) director-linked LLCs report sale of 5,101 shares

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

LifeStance Health Group, Inc. director Robert Bessler reported open-market sales of company common stock on April 21, 2026 through entities he is associated with. Shama LLC sold 2,550 shares and Vitthal LLC sold 2,551 shares at a weighted average price of $7.01 per share, within a range of $7.00 to $7.02.

After these sales, Shama LLC held 1,426,196 shares and Vitthal LLC held 1,309,397 shares of LifeStance common stock. Separate entries show 36,363 shares held indirectly, described as held by Alpine Glow Capital, and 57,619 shares held directly by Bessler. The reporting person disclaims beneficial ownership of the LLC- and Alpine Glow-held shares except to the extent of his pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider Bessler Robert
Role null
Sold 5,101 shs ($36K)
Type Security Shares Price Value
Sale Common Stock 2,551 $7.01 $18K
Sale Common Stock 2,550 $7.01 $18K
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 1,309,397 shares (Indirect, Vitthal LLC); Common Stock — 57,619 shares (Direct, null)
Footnotes (1)
  1. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.00 to $7.02 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act of 1934 (the "Exchange Act") or for any other purpose. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose. Shares held of record by Alpine Glow Capital. The Reporting Person is the manager and sole member of Alpine Glow Capital. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.
Shares sold by Shama LLC 2,550 shares Open-market sale on April 21, 2026 at $7.01 per share
Shares sold by Vitthal LLC 2,551 shares Open-market sale on April 21, 2026 at $7.01 per share
Net shares sold 5,101 shares Aggregate sales from reported transactions in this Form 4
Price range $7.00–$7.02 per share Range of prices for the reported sales on April 21, 2026
Shama LLC holdings after sale 1,426,196 shares Indirect LifeStance common stock position following transactions
Vitthal LLC holdings after sale 1,309,397 shares Indirect LifeStance common stock position following transactions
Alpine Glow Capital holdings 36,363 shares Indirect holdings reported with Bessler as manager and sole member
Direct holdings 57,619 shares Shares held directly by Robert Bessler after reported transactions
weighted average price financial
"The price reported is a weighted average price. These shares were sold in multiple transactions..."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
beneficial ownership financial
"The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest..."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein..."
Section 16 regulatory
"for purposes of Section 16 of the Exchange Act of 1934..."
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
indirect ownership financial
"Shares held of record by Alpine Glow Capital. The Reporting Person disclaims beneficial ownership..."
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bessler Robert

(Last)(First)(Middle)
C/O LIFESTANCE HEALTH GROUP, INC.
4800 N. SCOTTSDALE ROAD, SUITE 6000

(Street)
SCOTTSDALE ARIZONA 85251

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/21/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/21/2026S2,551D$7.01(1)1,309,397IVitthal LLC(2)
Common Stock04/21/2026S2,550D$7.01(1)1,426,196IShama LLC(3)
Common Stock57,619D
Common Stock36,363ISee Footnote(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.00 to $7.02 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
2. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act of 1934 (the "Exchange Act") or for any other purpose.
3. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.
4. Shares held of record by Alpine Glow Capital. The Reporting Person is the manager and sole member of Alpine Glow Capital. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.
By: /s/ Ryan Pardo, Attorney-in-Fact04/23/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did LifeStance Health Group (LFST) report for Robert Bessler?

LifeStance director Robert Bessler reported open-market sales of 5,101 shares of common stock on April 21, 2026. The trades were executed through Shama LLC and Vitthal LLC at a weighted average price of $7.01 per share within a $7.00–$7.02 range.

At what price were the LFST shares sold in the latest Form 4 filing?

The reported LFST shares were sold at a weighted average price of $7.01 per share. The transactions occurred in multiple trades between $7.00 and $7.02, with the filer offering to provide full trade-by-trade pricing details upon request to interested parties.

How many LifeStance (LFST) shares do Shama LLC and Vitthal LLC hold after the reported sales?

After the April 21, 2026 sales, Shama LLC held 1,426,196 LFST shares and Vitthal LLC held 1,309,397 shares. These holdings are reported as indirect interests related to director Robert Bessler, who disclaims beneficial ownership beyond his pecuniary interest in those entities.

Does Robert Bessler hold any LFST shares directly according to this Form 4?

Yes. The Form 4 shows Robert Bessler holding 57,619 shares of LifeStance common stock directly. Additional shares are reported as indirectly held through entities such as Shama LLC, Vitthal LLC, and Alpine Glow Capital, with beneficial ownership disclaimed except for his pecuniary interest.

What is Alpine Glow Capital’s role in the LFST insider holdings disclosure?

Alpine Glow Capital is reported as holding 36,363 LFST shares of record. Robert Bessler is described as the manager and sole member of Alpine Glow Capital, while disclaiming beneficial ownership of those securities beyond his pecuniary interest as required under Section 16 reporting rules.

How many LFST shares in total were sold in the reported insider transactions?

The Form 4 aggregates sales of 5,101 LFST shares across the reported transactions. Shama LLC sold 2,550 shares and Vitthal LLC sold 2,551 shares, both categorized as open-market or private sale transactions under code “S” in the Section 16 reporting framework.